Both AZD1208 treatment and PIM2 knockdown synergistically block cell proliferation, indicating that PIM kinase inhibitors are not sufficient to completely abolish PIM function in NHL. The gene discussed is PIM1; the disease is non-Hodgkin lymphoma.